Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-08-09

FDA Approved: AVIANE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for AVIANE, a fixed-dose combination oral contraceptive containing levonorgestrel and ethinyl estradiol, from Teva P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AVIANE (LEVONORGESTREL AND ETHINYL ESTRADIOL)

Snippet

SUPPL AP for AVIANE (LEVONORGESTREL AND ETHINYL ESTRADIOL)